浏览与细胞增殖紊乱、肿瘤学研究及抗增殖筛选相关的疾病导向型小分子。利用本页面围绕生长调控生物学、疾病机制及后续验证工作流程构建化合物集合。
细胞增殖性疾病
按类别选购
肠易激综合征(DOID:9778) irritable bowel syndrome (DOID:9778)
2,379多囊卵巢综合征(DOID:11612) polycystic ovary syndrome (DOID:11612)
2,022慢性疲劳综合征(DOID:8544) chronic fatigue syndrome (DOID:8544)
965努南综合征(DOID:3490) Noonan syndrome (DOID:3490)
81婴儿猝死综合征(DOID:9007) sudden infant death syndrome (DOID:9007)
41贝克威思-威德曼综合征(DOID:5572) Beckwith-Wiedemann syndrome (DOID:5572)
21心面皮肤综合征(DOID:0060233) cardiofaciocutaneous syndrome (DOID:0060233)
6Pitt-Hopkins综合征(DOID:0060488) Pitt-Hopkins syndrome (DOID:0060488)
229奥利尔病(DOID:4624) Ollier disease (DOID:4624)
7歌舞伎综合征(DOID:0060473) Kabuki syndrome (DOID:0060473)
126罗宾诺综合征(DOID:0060254) Robinow syndrome (DOID:0060254)
498CHARGE综合征(DOID:0050834) CHARGE syndrome (DOID:0050834)
44马夫奇综合征(DOID:0060221) Maffucci syndrome (DOID:0060221)
0施瓦赫曼-戴蒙德综合征(DOID:0060479) Shwachman-Diamond syndrome (DOID:0060479)
129高安氏动脉炎 (DOID:2508) Takayasu's arteritis (DOID:2508)
491卓-艾综合征(DOID:0050782) Zollinger-Ellison syndrome (DOID:0050782)
61Klippel-Trenaunay 综合征 (DOID:2926) Klippel-Trenaunay syndrome (DOID:2926)
8莫瓦特-威尔逊综合征(DOID:0060485) Mowat-Wilson syndrome (DOID:0060485)
65巴雷特瑟-温特综合征(DOID:0060229) Baraitser-Winter syndrome (DOID:0060229)
0EAST综合征(DOID:0060484) EAST syndrome (DOID:0060484)
167艾卡迪综合征(DOID:8461) Aicardi syndrome (DOID:8461)
47VACTERL综合征(DOID:14679) VACTERL association (DOID:14679)
11库伦·德弗里斯综合征 (DOID:0050880) Koolen de Vries syndrome (DOID:0050880)
24帕廷顿综合征(DOID:14744) Partington syndrome (DOID:14744)
22下颌面骨发育不全伴脱发(DOID:0060365) mandibulofacial dysostosis with alopecia (DOID:0060365)
81眼耳综合征 (DOID:0060482) oculoauricular syndrome (DOID:0060482)
30戈德堡-施普林岑综合征(DOID:0060481) Goldberg-Shprintzen syndrome (DOID:0060481)
22Lown-Ganong-Levine 综合征 (DOID:13087) Lown-Ganong-Levine syndrome (DOID:13087)
10Kleefstra 综合征 (DOID:0060352) Kleefstra syndrome (DOID:0060352)
23致死性先天性挛缩综合征(DOID:0060558) lethal congenital contracture syndrome (DOID:0060558)
10正中弓状韧带综合征(DOID:9892) median arcuate ligament syndrome (DOID:9892)
26产品列表
-
2-fluoro-N-methyl-4-[[4-(2-methyl-3-propan-2-ylimidazol-4-yl)pyrimidin-2-yl]amino]benzamide化合物 CID: 11675054Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: F609478查看产品价格与包装
技术标识符
- IUPAC名称
- 2-fluoro-N-methyl-4-[[4-(2-methyl-3-propan-2-ylimidazol-4-yl)pyrimidin-2-yl]amino]benzamide
- SMILES
- CNC(=O)c1ccc(cc1F)Nc1nccc(n1)c1cnc(n1C(C)C)C
- InChIKey
- OCUYCOQPRGFQEV-UHFFFAOYSA-N
- InChI
- 1S/C19H21FN6O/c1-11(2)26-12(3)23-10-17(26)16-7-8-22-19(25-16)24-13-5-6-14(15(20)9-13)18(27)21-4/h5-11H,1-4H3,(H,21,27)(H,22,24,25)
-
2-[[3,4-dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide化合物 CID: 25207521Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609117查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[[3,4-dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide
- SMILES
- Oc1cccc(c1)C(C(=O)N)NC1=C(C(=O)C1=O)Nc1ccncc1
- InChIKey
- GPXKVULNYYNGDP-UHFFFAOYSA-N
- InChI
- 1S/C17H14N4O4/c18-17(25)12(9-2-1-3-11(22)8-9)21-14-13(15(23)16(14)24)20-10-4-6-19-7-5-10/h1-8,12,21-22H,(H2,18,25)(H,19,20)
-
2-[(6-chloro-7-methyl-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)-methylsulfonylamino]acetic acid化合物 CID: 9863759Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C609466查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[(6-chloro-7-methyl-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)-methylsulfonylamino]acetic acid
- SMILES
- OC(=O)CN(S(=O)(=O)C)c1c(Cl)c(C)cc2c1[nH]c(=O)c(=O)[nH]2
- InChIKey
- JQCXJCAKYWSWCH-UHFFFAOYSA-N
- InChI
- 1S/C12H12ClN3O6S/c1-5-3-6-9(15-12(20)11(19)14-6)10(8(5)13)16(4-7(17)18)23(2,21)22/h3H,4H2,1-2H3,(H,14,19)(H,15,20)(H,17,18)
-
2-[2-[[5-[(4-fluorophenyl)methyl]-1-[(4-methoxyphenyl)methyl]-4,6-dioxo-1,3,5-triazin-2-yl]amino]ethyl]guanidineMoligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: F614531查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[2-[[5-[(4-fluorophenyl)methyl]-1-[(4-methoxyphenyl)methyl]-4,6-dioxo-1,3,5-triazin-2-yl]amino]ethyl]guanidine
- SMILES
- COc1ccc(cc1)Cn1c(NCCNC(=N)N)nc(=O)n(c1=O)Cc1ccc(cc1)F
- InChIKey
- INQAREWWDULMAD-UHFFFAOYSA-N
- InChI
- 1S/C21H24FN7O3/c1-32-17-8-4-15(5-9-17)12-28-19(26-11-10-25-18(23)24)27-20(30)29(21(28)31)13-14-2-6-16(22)7-3-14/h2-9H,10-13H2,1H3,(H4,23,24,25)(H,26,27,30)
-
2-[3-(7-hydroxy-4,5-dihydropyrazolo[1,5-a]quinolin-3-yl)propanoylamino]benzoic acid化合物 CID: 11494579Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: H609064查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[3-(7-hydroxy-4,5-dihydropyrazolo[1,5-a]quinolin-3-yl)propanoylamino]benzoic acid
- SMILES
- O=C(Nc1ccccc1C(=O)O)CCc1cnn2c1CCc1c2ccc(c1)O
- InChIKey
- PCUNTWOSLIUDRR-UHFFFAOYSA-N
- InChI
- 1S/C21H19N3O4/c25-15-7-9-18-13(11-15)5-8-19-14(12-22-24(18)19)6-10-20(26)23-17-4-2-1-3-16(17)21(27)28/h1-4,7,9,11-12,25H,5-6,8,10H2,(H,23,26)(H,27,28)
-
2-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-indazol-6-yl}phenol化合物 CID: 135928471Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M609187查看产品价格与包装
技术标识符
- IUPAC名称
- 2-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-indazol-6-yl}phenol
- SMILES
- COc1cc(ccc1O)c1ccc2c(c1)[nH]nc2c1nc2c([nH]1)cccc2N1CCN(CC1)C
- InChIKey
- KKMLIJHOUUKCSW-UHFFFAOYSA-N
- InChI
- 1S/C26H26N6O2/c1-31-10-12-32(13-11-31)21-5-3-4-19-25(21)28-26(27-19)24-18-8-6-16(14-20(18)29-30-24)17-7-9-22(33)23(15-17)34-2/h3-9,14-15,33H,10-13H2,1-2H3,(H,27,28)(H,29,30)
-
4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide化合物 CID: 145994392Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: E610619查看产品价格与包装
技术标识符
- IUPAC名称
- 4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide
- SMILES
- CCN1CCN(CC1)C(=O)Nc1nccc(c1)c1cn(c2c1ccnc2)C1CCOCC1
- InChIKey
- SAZIAQSVBIWIDU-UHFFFAOYSA-N
- InChI
- 1S/C24H30N6O2/c1-2-28-9-11-29(12-10-28)24(31)27-23-15-18(3-8-26-23)21-17-30(19-5-13-32-14-6-19)22-16-25-7-4-20(21)22/h3-4,7-8,15-17,19H,2,5-6,9-14H2,1H3,(H,26,27,31)
-
2-[4-[2-[5-(2,2-dimethylbutyl)-1H-imidazol-2-yl]ethyl]phenyl]benzoic acidMoligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608951查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[4-[2-[5-(2,2-dimethylbutyl)-1H-imidazol-2-yl]ethyl]phenyl]benzoic acid
- SMILES
- CCC(Cc1c[nH]c(n1)CCc1ccc(cc1)c1ccccc1C(=O)O)(C)C
- InChIKey
- AXHVEQQLKVIZLO-UHFFFAOYSA-N
- InChI
- 1S/C24H28N2O2/c1-4-24(2,3)15-19-16-25-22(26-19)14-11-17-9-12-18(13-10-17)20-7-5-6-8-21(20)23(27)28/h5-10,12-13,16H,4,11,14-15H2,1-3H3,(H,25,26)(H,27,28)
-
2-methyl-3-phenethyl-3H-pyrimidin-4-oneMoligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M607131查看产品价格与包装
技术标识符
- IUPAC名称
- (2E)-5-ethyl-3-[2-(2-fluorophenyl)ethyl]-6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-one
- SMILES
- CCc1c(C)[nH]/c(=C\2/C=CC=CC2=O)/n(c1=O)CCc1ccccc1F
- InChIKey
- FYHAHJQDCZYGNJ-LVZFUZTISA-N
- InChI
- 1S/C21H21FN2O2/c1-3-16-14(2)23-20(17-9-5-7-11-19(17)25)24(21(16)26)13-12-15-8-4-6-10-18(15)22/h4-11,23H,3,12-13H2,1-2H3/b20-17+
-
2-[4-[3-(4-fluorophenoxy)-5-[[3-hydroxy-3-(2-methylpropyl)pyrrolidine-1-carbonyl]amino]phenoxy]phenyl]-2-methylpropanoic acid化合物 CID: 90309142Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: F608775查看产品价格与包装
技术标识符
- IUPAC名称
- 2-[4-[3-(4-fluorophenoxy)-5-[[3-hydroxy-3-(2-methylpropyl)pyrrolidine-1-carbonyl]amino]phenoxy]phenyl]-2-methylpropanoic acid
- SMILES
- Fc1ccc(cc1)Oc1cc(Oc2ccc(cc2)C(C(=O)O)(C)C)cc(c1)NC(=O)N1CCC(C1)(O)CC(C)C
- InChIKey
- WCDFXVWDGHHCSI-UHFFFAOYSA-N
- InChI
- 1S/C31H35FN2O6/c1-20(2)18-31(38)13-14-34(19-31)29(37)33-23-15-26(17-27(16-23)40-25-11-7-22(32)8-12-25)39-24-9-5-21(6-10-24)30(3,4)28(35)36/h5-12,15-17,20,38H,13-14,18-19H2,1-4H3,(H,33,37)(H,35,36)
-
2-methoxy-α,β-didehydro-agomelatine化合物 CID: 71533431Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M607129查看产品价格与包装
技术标识符
- IUPAC名称
- N-[(E)-2-(2,7-dimethoxynaphthalen-1-yl)ethenyl]acetamide
- SMILES
- COc1ccc2c(c1/C=C/NC(=O)C)cc(cc2)OC
- InChIKey
- HMYFXYOFPXZULT-CMDGGOBGSA-N
- InChI
- 1S/C16H17NO3/c1-11(18)17-9-8-14-15-10-13(19-2)6-4-12(15)5-7-16(14)20-3/h4-10H,1-3H3,(H,17,18)/b9-8+
-
2-methyl-N-(2-{[3-(prop-2-enamido)phenyl]amino}pyrimidin-5-yl)-5-[3-(trifluoromethyl)benzamido]benzamide化合物 CID: 71519693Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M609107查看产品价格与包装
技术标识符
- IUPAC名称
- 2-methyl-N-(2-{[3-(prop-2-enamido)phenyl]amino}pyrimidin-5-yl)-5-[3-(trifluoromethyl)benzamido]benzamide
- SMILES
- C=CC(=O)Nc1cccc(c1)Nc1ncc(cn1)NC(=O)c1cc(ccc1C)NC(=O)c1cccc(c1)C(F)(F)F
- InChIKey
- BTWVWABAWDKQNJ-UHFFFAOYSA-N
- InChI
- 1S/C29H23F3N6O3/c1-3-25(39)35-20-8-5-9-21(13-20)38-28-33-15-23(16-34-28)37-27(41)24-14-22(11-10-17(24)2)36-26(40)18-6-4-7-19(12-18)29(30,31)32/h3-16H,1H2,2H3,(H,35,39)(H,36,40)(H,37,41)(H,33,34,38)
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
应如何使用细胞增殖性疾病分类?
可用细胞增殖性疾病快速组建候选化合物集,再逐一对照各化合物的靶点页面及其活性检测方法进行核实。疾病注释反映的是已报道的关联性,而非已验证的适应症。
细胞增殖性疾病与目录其他部分是什么关系?
细胞增殖性疾病归属于按疾病分类(DOID),是按疾病注释组织的视图,其中化合物同时也收录在各自的分子靶点下。可用它快速圈定范围,再在靶点页面逐一确认。
从细胞增殖性疾病订购化合物前应核查什么?
对于细胞增殖性疾病中的任何化合物,请核查所报道活性的检测方法、种属相关性、纯度,以及推荐的母液溶剂和储存条件。批次专属数据见分析证书。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
可以为细胞增殖性疾病定制化合物集吗?
细胞增殖性疾病下的化合物可按靶点、作用机制和化合物类别筛选,并可按您指定的板型提供按需挑选的化合物集。需求请提交至 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![2-fluoro-N-methyl-4-[[4-(2-methyl-3-propan-2-ylimidazol-4-yl)pyrimidin-2-yl]amino]benzamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F609478.png)
![2-[[3,4-dioxo-2-(pyridin-4-ylamino)cyclobuten-1-yl]amino]-2-(3-hydroxyphenyl)acetamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609117.png)
![2-[(6-chloro-7-methyl-2,3-dioxo-1,4-dihydroquinoxalin-5-yl)-methylsulfonylamino]acetic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C609466.png)
![2-[2-[[5-[(4-fluorophenyl)methyl]-1-[(4-methoxyphenyl)methyl]-4,6-dioxo-1,3,5-triazin-2-yl]amino]ethyl]guanidine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F614531.png)
![2-[3-(7-hydroxy-4,5-dihydropyrazolo[1,5-a]quinolin-3-yl)propanoylamino]benzoic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/H/6/H609064.png)
![2-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-indazol-6-yl}phenol](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M609187.png)
![4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/E/6/E610619.png)
![2-[4-[2-[5-(2,2-dimethylbutyl)-1H-imidazol-2-yl]ethyl]phenyl]benzoic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608951.png)

![2-[4-[3-(4-fluorophenoxy)-5-[[3-hydroxy-3-(2-methylpropyl)pyrrolidine-1-carbonyl]amino]phenoxy]phenyl]-2-methylpropanoic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/F/6/F608775.png)

![2-methyl-N-(2-{[3-(prop-2-enamido)phenyl]amino}pyrimidin-5-yl)-5-[3-(trifluoromethyl)benzamido]benzamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M609107.png)
危险品化学品经营许可证(带存储)